Surveillance of public health pathogens in Lagos wastewater canals: a cross-sectional study.

Surveillance of public health pathogens in Lagos wastewater canals: a cross-sectional study.

Publication date: Dec 26, 2024

Wastewater-based epidemiology (WBE) is already being adopted for the surveillance of health conditions of communities and shows great potential for the monitoring of infectious pathogens of public health importance. There is however paucity of robust data to support extensive WBE in Nigeria. This study evaluated the prevalence of clinically relevant infectious pathogens and provided antimicrobial resistance profiles of bacteria pathogens in wastewater canals in Lagos State at a single point in time. This is a cross-sectional survey of wastewater canals in 20 Local Government Areas (LGAs) in Lagos State for detection of bacteria pathogens of public health importance including non-tuberculous mycobacteria and SARS-Cov-2 virus using cultural analysis and conventional Polymerase Chain Reaction (PCR) techniques. Descriptive epidemiological survey of communities around the canals was done using questionnaires to assess exposure pathways. Statistical analysis was done using SPSS version 27 while P value of 

Open Access PDF

Concepts Keywords
Epidemiological Antimicrobial resistance
Extensive Antimicrobial resistance genes
Mycobacteria Escherichia coli
Nigeria Lagos
Pcr Mycobacterium fortitium
Mycobacterium kansasii
Pathogen detection
Public health surveillance
Vibrio cholera
Wastewater-based epidemiology

Semantics

Type Source Name
disease IDO bacteria
pathway REACTOME Reproduction
drug DRUGBANK Water
disease IDO pathogen
drug DRUGBANK Coenzyme M
disease IDO pathogen surveillance
disease MESH morbidity
disease MESH Tuberculosis
pathway KEGG Tuberculosis
disease IDO immunosuppression
drug DRUGBANK Trestolone
disease MESH COVID 19
disease MESH infection
drug DRUGBANK Azithromycin
disease IDO history
disease MESH cholera
drug DRUGBANK Huperzine B
disease IDO site
disease IDO country
drug DRUGBANK Ademetionine
drug DRUGBANK Etoperidone
drug DRUGBANK L-Arginine
drug DRUGBANK Amphotericin B
disease IDO nucleic acid
disease IDO assay
drug DRUGBANK Estrone sulfate
drug DRUGBANK Sucrose
disease IDO blood
drug DRUGBANK Mannitol
disease IDO facility
disease IDO susceptibility
drug DRUGBANK Ampicillin
drug DRUGBANK Clarithromycin
drug DRUGBANK Cefotaxime
drug DRUGBANK Ceftazidime
drug DRUGBANK Imipenem
drug DRUGBANK Tetracycline
drug DRUGBANK Ciprofloxacin
drug DRUGBANK Sulfamethoxazole
drug DRUGBANK Sulfamethazine
drug DRUGBANK Thymidine monophosphate
drug DRUGBANK Amikacin
drug DRUGBANK Levofloxacin
drug DRUGBANK Ceftriaxone
disease MESH bacterial infections
drug DRUGBANK Meticillin
drug DRUGBANK Flunarizine
drug DRUGBANK Tropicamide
drug DRUGBANK Albendazole
drug DRUGBANK Trihexyphenidyl
drug DRUGBANK Timonacic
drug DRUGBANK 5-amino-1 3 4-thiadiazole-2-thiol
drug DRUGBANK Thiocolchicoside
drug DRUGBANK 7-Methyl-Gpppa
drug DRUGBANK Tretamine
drug DRUGBANK Methyl 4 6-O-[(1r)-1-Carboxyethylidene]-Beta-D-Galactopyranoside
disease MESH Marital Status
drug DRUGBANK Erythromycin
disease IDO antibiotic resistance
disease IDO intervention
disease MESH dehydration
disease MESH tic
disease MESH community transmission
disease MESH nosocomial infections
disease MESH clinical significance
disease MESH soft tissue infection
drug DRUGBANK Medical air
disease MESH infectious diseases
drug DRUGBANK Methylergometrine
disease IDO algorithm
disease MESH malaria
pathway KEGG Malaria
disease MESH death
disease MESH Tetracycline Resistance
disease MESH viral shedding
drug DRUGBANK Guanosine
drug DRUGBANK Honey
drug DRUGBANK Zinc
disease MESH urinary tract infections

Original Article

(Visited 1 times, 1 visits today)